To elucidate the role of IGF2BP1 in breast cancer, we first interrogated large publicly available datasets from METABRIC using cBioPortal and analyzed genetic alterations in IGF2BP1 that included mRNA amplifaction, deletion or level changes and their correlation with clinical values. Here, IGF2BP1 is linked to breast carcinoma.